Exagen inc. to participate in the 2023 btig medtech, digital health, life science & diagnostic tools conference

San diego, jan. 30, 2023 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the btig medtech, digital health, life science & diagnostic tools conference, which takes place february 14-16, 2023 in snowbird, ut. management will be participating in one-on-one meetings with investors during the event; meetings can be requested through btig.
XGN Ratings Summary
XGN Quant Ranking